GMAB

E854985

GMAB is the stock ticker symbol for Genmab A/S, a Danish biotechnology company specializing in the development of antibody-based cancer therapies.

Try in SPARQL Jump to: Surface forms Statements Referenced by

Observed surface forms (2)

Surface form Occurrences
Genmab A/S 0
daratumumab 0

Statements (46)

Predicate Object
instanceOf biotechnology company
monoclonal antibody
stock ticker symbol
coreBusiness research and development of antibody therapeutics
country Denmark
currency Danish krone NERFINISHED
developedBy Genmab A/S NERFINISHED
develops antibody-drug conjugates
bispecific antibodies
monoclonal antibody therapeutics
focusesOn immuno-oncology
oncology
foundedBy Florian Schönharting NERFINISHED
Jan G. J. van de Winkel NERFINISHED
Medarex, Inc. NERFINISHED
foundingYear 1999
hasADR GMAB NERFINISHED
hasCollaborationWith AbbVie NERFINISHED
BioNTech NERFINISHED
Janssen Biotech NERFINISHED
Roche NERFINISHED
Seagen NERFINISHED
headquartersLocation Copenhagen, Denmark NERFINISHED
indication multiple myeloma
industry biotechnology
pharmaceuticals
ISIN DK0010272202
DK0010272202
legalForm Aktieselskab
listedAs GMAB NERFINISHED
listedOn NASDAQ Global Select Market NERFINISHED
marketedAs Darzalex NERFINISHED
notableProduct daratumumab
primaryListing NASDAQ Copenhagen NERFINISHED
represents Genmab A/S NERFINISHED
secondaryListing NASDAQ Global Select Market NERFINISHED
securityType equity
segment large-cap biotech
specializesIn antibody-based cancer therapies
technologyPlatform antibody discovery platform
tradesOn NASDAQ Copenhagen NERFINISHED
NASDAQ Global Select Market NERFINISHED
treatsDiseaseArea hematologic malignancies
solid tumors
underlyingCompany Genmab A/S NERFINISHED
website https://www.genmab.com

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Genmab tickerSymbol GMAB